TH94332A - Gamma cystase inhibitor, ring-welded tricyclic sulfonamide group - Google Patents

Abstract

DC60 (24/08/50) Invention produces a compound of Formula I (chemical formula) or a pharmaceutical salt of the foregoing, where R1, R2 and the A, B, and C rings comply. The definition is already stated here. Formula I compound is useful in treatment. Or prevent peripheral disease, such as Alzheimer's disease Invention also includes Pharmacy including Compounds or salts of formula I, methods for preparing compounds for intended use and methods of treatment for peripheral diseases such as Alzheimer's disease. By using a compound or salt of Formula I, the invention produces a compound of Formula I: (chemical formula) or a pharmaceutical salt of the foregoing, where R1, R2 and the A, B, and C rings are According to the definition as already stated here Formula I compound is useful in treatment. Or prevent peripheral disease, such as Alzheimer's disease Invention also includes Pharmacy including Compounds or salts of formula I, methods for preparing compounds for intended use and methods of treatment for peripheral diseases such as Alzheimer's disease. Using compound or formula I salts: patent medicine

Claims (1)

1. Compounds having formulas: (chemical formula), stereoisomers, tautomers, mixtures of stereo isomers and / or tautomers or pharmacologically acceptable salts of matter. As mentioned above, where the C ring is cycloalkyl, aeryl, heterocyclic alkyl, or heterocyclicylkyl, each has a Select is replaced by 1,2,3 or 4 groups independently of halogen, C1-C6 alkyl, C1-C6 alkyl, aeryloxi, aeryl - (C1-C6 L Cox C), C1-C6 Haloalkyl, C1-C6 Haloctag: Drug Patent